EUVIMEDEUVIMED entdecken
Crossref

Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments

Kelleni MT

Diabetes & Obesity International Journal · 2018

DOI: 10.23880/doij-16000106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Obesity International Journal, 2018. Verfasst von Kelleni MT.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

MT, K. (2018). Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments. Diabetes & Obesity International Journal. https://doi.org/10.23880/doij-16000106

Vancouver

MT K. Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments. Diabetes & Obesity International Journal. 2018. doi:10.23880/doij-16000106

BibTeX
@article{MT2018,
  author = {MT, Kelleni},
  title = {Amyloid Antagonists: The Future of Type 2 Diabetes as well as Several Neurodegenerative Diseases Treatments},
  journal = {Diabetes & Obesity International Journal},
  year = {2018},
  doi = {10.23880/doij-16000106}
}
Kostenlos starten →